| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee3727dba91e4e7aa3b26ce9efbcc21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate |
2006-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ad44d82818dd33c9721385a92e04e78 |
| publicationDate |
2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008255170-A1 |
| titleOfInvention |
Process for the Synthesis of Rosuvastatin Calcium |
| abstract |
Present invention represents process for the preparation of HMG-CoA reductase inhibitors, in particular rosuvastatin calcium introducing L-malic acid as the source of chirality for the side chain. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010048899-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009312547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8212035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008161560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106674281-A |
| priorityDate |
2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |